» Articles » PMID: 34794816

Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer

Overview
Specialty Gastroenterology
Date 2021 Nov 19
PMID 34794816
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. This update is restricted to addressing the age to start and stop CRC screening in average-risk individuals and the recommended screening modalities. Although there is no literature demonstrating that CRC screening in individuals under age 50 improves health outcomes such as CRC incidence or CRC-related mortality, sufficient data support the U.S. Multi-Society Task Force to suggest average-risk CRC screening begin at age 45. This recommendation is based on the increasing disease burden among individuals under age 50, emerging data that the prevalence of advanced colorectal neoplasia in individuals ages 45 to 49 approaches rates in individuals 50 to 59, and modeling studies that demonstrate the benefits of screening outweigh the potential harms and costs. For individuals ages 76 to 85, the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference. Screening is not recommended after age 85.

Citing Articles

Linking LEDGF/p75 Overexpression With Microsatellite Instability and KRAS Mutations: A Small-Scale Study in Colorectal Cancer.

Liedtke V, Wartmann T, Shi W, Kahlert U Cancer Control. 2025; 32:10732748251313499.

PMID: 39965614 PMC: 11837075. DOI: 10.1177/10732748251313499.


Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States.

Le Q, Greene M, Gohil S, Ozbay A, Dore M, Fendrick A Int J Colorectal Dis. 2025; 40(1):16.

PMID: 39825079 PMC: 11741991. DOI: 10.1007/s00384-025-04805-0.


Impact of Multimorbidity Burden on Mortality Risk among Colon Cancer Survivors.

Wang S, Koseki M, Sheu M, Li H, Lin Y, Yang C J Cancer. 2025; 16(2):558-566.

PMID: 39744491 PMC: 11685689. DOI: 10.7150/jca.103438.


An Estimate of Preventable Harms Associated With Screening Colonoscopy Overuse in the U.S.

Brownlee S, Huffstetler A, Fraiman J, Lin K AJPM Focus. 2024; 4(1):100296.

PMID: 39698330 PMC: 11653136. DOI: 10.1016/j.focus.2024.100296.


Validation of Artificial Intelligence Computer-Aided Detection of Colonic Neoplasm in Colonoscopy.

Lee H, Chung J, Kim K, Kwon K, Kim J, Yun S Diagnostics (Basel). 2024; 14(23).

PMID: 39682670 PMC: 11640539. DOI: 10.3390/diagnostics14232762.